NCT00232414View on ClinicalTrials.gov

A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Bipolar I Disorder
Interventions
DRUG

Quetiapine

Trial Locations (1)

45267-0559

University of Cincinnati Medical Center, Cincinnati

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

University of Cincinnati

OTHER